Clinical trial

B181 Metobes-III: Weight Loss Maintenance of a New Bioactive Compound (Metobes-Long)

NCT00302263

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Metobes-compound Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

B181 Metobes-III: Weight Loss Maintenance of a New Bioactive Compound (Metobes-Long)

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2, PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-01-01

PhasePHASE2 / PHASE3

Conditions

Obesityverified · MONDO: obesity disorder

Interventions

Metobes-compoundDRUG

Sponsors & collaborators

University of Copenhagenlead sponsor

Metabolifecollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00302263 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.